bs_bs_banner
Geriatr Gerontol Int 2014; 14: 954–959
ORIGINAL ARTICLE: EPIDEMIOLOGY, CLINICAL PRACTICE AND HEALTH
Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry Ryu Matsuo,1 Masahiro Kamouchi,2 Tetsuro Ago,1 Jun Hata,1 Yuji Shono,1 Junya Kuroda,1 Yoshinobu Wakisaka,1 Hiroshi Sugimori1 and Takanari Kitazono1 for the FSR investigators Departments of 1Medicine and Clinical Science and 2Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Aim: The present study aimed to determine the efficacy and safety of thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) therapy in older patients compared with younger patients. Methods: Using the Fukuoka Stroke Registry, a prospective multicenter study for acute stroke in Japan, we analyzed data of 401 patients with acute ischemic stroke (aged 74.5 ± 13.1 years) treated with thrombolytic therapy using rt-PA. Patients were categorized into two groups according to age: those aged ≥75 years (n = 240) and
Geriatr Gerontol Int 2014; 14: 954–959
ORIGINAL ARTICLE: EPIDEMIOLOGY, CLINICAL PRACTICE AND HEALTH
Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry Ryu Matsuo,1 Masahiro Kamouchi,2 Tetsuro Ago,1 Jun Hata,1 Yuji Shono,1 Junya Kuroda,1 Yoshinobu Wakisaka,1 Hiroshi Sugimori1 and Takanari Kitazono1 for the FSR investigators Departments of 1Medicine and Clinical Science and 2Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Aim: The present study aimed to determine the efficacy and safety of thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) therapy in older patients compared with younger patients. Methods: Using the Fukuoka Stroke Registry, a prospective multicenter study for acute stroke in Japan, we analyzed data of 401 patients with acute ischemic stroke (aged 74.5 ± 13.1 years) treated with thrombolytic therapy using rt-PA. Patients were categorized into two groups according to age: those aged ≥75 years (n = 240) and
